Geneos Wealth Management Inc. Greenwich Life Sciences, Inc. Transaction History
Geneos Wealth Management Inc.
- $2.6 Billion
- Q3 2024
A detailed history of Geneos Wealth Management Inc. transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 88 shares of GLSI stock, worth $1,034. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88
Previous 88
-0.0%
Holding current value
$1,034
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GLSI
# of Institutions
38Shares Held
1.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$3.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA274KShares$3.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA134KShares$1.57 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.02 Million0.01% of portfolio
-
Northern Trust Corp Chicago, IL74.5KShares$875,3750.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $151M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...